Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents

Verfasser / Beitragende:
[Christophe Le Tourneau, Véronique Diéras, Patricia Tresca, Wulfran Cacheux, Xavier Paoletti]
Ort, Verlag, Jahr:
2010
Enthalten in:
Targeted Oncology, 5/1(2010-03-01), 65-72
Format:
Artikel (online)
ID: 445168919